$SONX
Sonendo, Inc.

2021 Q4 Form 10-Q Financial Statement

#000095017021005123 Filed on December 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $9.891M $7.887M $6.132M
YoY Change -57.64% 28.62%
Cost Of Revenue $7.439M $5.838M $4.931M
YoY Change -61.78% 18.39%
Gross Profit $2.452M $2.049M $1.201M
YoY Change -36.89% 70.61%
Gross Profit Margin 24.79% 25.98% 19.59%
Selling, General & Admin $11.31M $8.495M $5.802M
YoY Change -57.62% 46.42%
% of Gross Profit 461.38% 414.59% 483.1%
Research & Development $4.258M $4.633M $4.920M
YoY Change -79.19% -5.83%
% of Gross Profit 173.65% 226.11% 409.66%
Depreciation & Amortization $483.0K $503.0K
YoY Change -71.64%
% of Gross Profit 19.7% 24.55%
Operating Expenses $16.02M $13.15M $10.75M
YoY Change -65.68% 22.27%
Operating Profit -$13.57M -$11.10M -$9.551M
YoY Change -68.3% 16.2%
Interest Expense -$388.0K -$1.476M
YoY Change -90.79%
% of Operating Profit
Other Income/Expense, Net $247.0K -$159.0K
YoY Change -28.61%
Pretax Income -$13.71M -$12.73M -$10.59M
YoY Change -70.62% 20.2%
Income Tax $2.000K
% Of Pretax Income
Net Earnings -$13.71M -$12.73M -$10.59M
YoY Change -70.62% 20.2%
Net Earnings / Revenue -138.62% -161.44% -172.75%
Basic Earnings Per Share -$10.33
Diluted Earnings Per Share -$520.0K -$483.7K
COMMON SHARES
Basic Shares Outstanding 26.33M 1.233M
Diluted Shares Outstanding 1.233M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $84.64M $13.75M
YoY Change
Cash & Equivalents $84.64M $13.70M $59.49M
Short-Term Investments
Other Short-Term Assets $3.552M $3.357M
YoY Change
Inventory $8.150M $7.236M
Prepaid Expenses
Receivables $2.516M $1.914M
Other Receivables $0.00 $0.00
Total Short-Term Assets $98.86M $26.26M
YoY Change 67.86%
LONG-TERM ASSETS
Property, Plant & Equipment $2.366M $2.527M
YoY Change -24.96%
Goodwill $8.454M $8.454M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $118.0K $115.0K
YoY Change -4.07%
Total Long-Term Assets $16.64M $17.16M
YoY Change -3.51%
TOTAL ASSETS
Total Short-Term Assets $98.86M $26.26M
Total Long-Term Assets $16.64M $17.16M
Total Assets $115.5M $43.42M
YoY Change 51.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.061M $1.987M
YoY Change 58.6%
Accrued Expenses $4.758M $4.476M
YoY Change 46.54%
Deferred Revenue $771.0K $684.0K
YoY Change -8.0%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.65M $12.80M
YoY Change -64.09%
LONG-TERM LIABILITIES
Long-Term Debt $26.50M $26.37M
YoY Change
Other Long-Term Liabilities $558.0K $469.0K
YoY Change -28.09%
Total Long-Term Liabilities $27.05M $26.84M
YoY Change 3386.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.65M $12.80M
Total Long-Term Liabilities $27.05M $26.84M
Total Liabilities $43.44M $49.13M
YoY Change -10.79%
SHAREHOLDERS EQUITY
Retained Earnings -$312.0M -$298.3M
YoY Change 18.4%
Common Stock $384.2M $11.33M
YoY Change 3858.35%
Preferred Stock
YoY Change
Treasury Stock (at cost) $51.00K $51.00K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $72.06M -$287.1M -$241.8M
YoY Change
Total Liabilities & Shareholders Equity $115.5M $43.42M
YoY Change 51.69%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$13.71M -$12.73M -$10.59M
YoY Change -70.62% 20.2%
Depreciation, Depletion And Amortization $483.0K $503.0K
YoY Change -71.64%
Cash From Operating Activities -$14.72M -$10.02M
YoY Change -2.38%
INVESTING ACTIVITIES
Capital Expenditures -$191.0K -$255.0K
YoY Change -65.71%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$191.0K -$255.0K
YoY Change -65.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 85.81M -1.711M
YoY Change -1716280.0%
NET CHANGE
Cash From Operating Activities -14.72M -10.02M
Cash From Investing Activities -191.0K -255.0K
Cash From Financing Activities 85.81M -1.711M
Net Change In Cash 70.89M -11.98M
YoY Change -553.11%
FREE CASH FLOW
Cash From Operating Activities -$14.72M -$10.02M
Capital Expenditures -$191.0K -$255.0K
Free Cash Flow -$14.53M -$9.760M
YoY Change 0.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4715000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1593000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2756000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001407973
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13748000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40988
dei Entity Registrant Name
EntityRegistrantName
Sonendo, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5041718
dei Entity Address Address Line1
EntityAddressAddressLine1
26061 Merit Circle
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 102
dei Entity Address City Or Town
EntityAddressCityOrTown
Laguna Hills
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92653
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
766-3636
dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
SONX
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Bankruptcy Proceedings Reporting Current
EntityBankruptcyProceedingsReportingCurrent
true
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26334216
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51722000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1914000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1934000
CY2021Q3 us-gaap Inventory Net
InventoryNet
7236000
CY2020Q4 us-gaap Inventory Net
InventoryNet
4338000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3357000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
901000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
26255000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
58895000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2527000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3153000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2943000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3308000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3122000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2208000
CY2021Q3 us-gaap Goodwill
Goodwill
8454000
CY2020Q4 us-gaap Goodwill
Goodwill
8454000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
12798000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
40801000
CY2021Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
4225000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
115000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
123000
CY2021Q3 us-gaap Assets
Assets
43416000
CY2020Q4 us-gaap Assets
Assets
76141000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1987000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1930000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4476000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3247000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3391000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3714000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
935000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
802000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
28352000
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2009000
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1914000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1964000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2449000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
26374000
CY2021Q3 sonx Forward Obligation Noncurrent
ForwardObligationNoncurrent
3300000
CY2020Q4 sonx Forward Obligation Noncurrent
ForwardObligationNoncurrent
2750000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
469000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
776000
CY2021Q3 us-gaap Liabilities
Liabilities
49130000
CY2020Q4 us-gaap Liabilities
Liabilities
48690000
CY2021Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
17528207
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
17528207
CY2021Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
17031887
CY2021Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
17031887
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
17031887
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
17031887
CY2021Q3 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
282198000
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
282198000
CY2021Q3 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
281342000
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
281342000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21643836
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21643836
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1305634
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1247024
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1258945
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1200335
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11326000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
9703000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-298333000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-263545000
CY2021Q3 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
-287005000
CY2020Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
-253840000
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
51000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
51000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-287056000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-253891000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43416000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76141000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7887000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6132000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11098000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9551000
us-gaap Operating Income Loss
OperatingIncomeLoss
-30838000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23306000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14680000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5838000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4931000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17422000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12550000
CY2021Q3 us-gaap Gross Profit
GrossProfit
2049000
CY2020Q3 us-gaap Gross Profit
GrossProfit
1201000
us-gaap Gross Profit
GrossProfit
5884000
us-gaap Gross Profit
GrossProfit
2130000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8495000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5802000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22400000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19423000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4633000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4920000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14310000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14551000
CY2021Q3 sonx Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
19000
CY2020Q3 sonx Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
30000
sonx Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
12000
sonx Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
-478000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
13147000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
10752000
us-gaap Operating Expenses
OperatingExpenses
36722000
us-gaap Operating Expenses
OperatingExpenses
33496000
us-gaap Operating Income Loss
OperatingIncomeLoss
-31366000
CY2021Q3 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-1076000
CY2020Q3 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-1080000
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-3224000
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-2877000
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
159000
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-38000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
176000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-105000
CY2021Q3 sonx Change In Fair Value Of Forward Obligation
ChangeInFairValueOfForwardObligation
-400000
sonx Change In Fair Value Of Forward Obligation
ChangeInFairValueOfForwardObligation
-550000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12733000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10593000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34788000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34138000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12733000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-10593000
us-gaap Net Income Loss
NetIncomeLoss
-34788000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
494000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-10906000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-264270000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
56000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
413000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-11149000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-274950000
us-gaap Net Income Loss
NetIncomeLoss
-34138000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-10.33
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-8.84
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-28.54
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-28.58
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1232921
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1197919
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1218815
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1194562
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-208914000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
268000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-13001000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-221634000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
442000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-10544000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-231721000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
465000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-10593000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-241836000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-253891000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
33000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
86000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
541000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12733000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-287056000
us-gaap Profit Loss
ProfitLoss
-34788000
us-gaap Profit Loss
ProfitLoss
-34138000
us-gaap Depreciation
Depreciation
1109000
us-gaap Depreciation
Depreciation
1620000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
420000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
398000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
726000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
714000
us-gaap Share Based Compensation
ShareBasedCompensation
1448000
us-gaap Share Based Compensation
ShareBasedCompensation
1175000
sonx Provision For Excess And Obsolete Inventory
ProvisionForExcessAndObsoleteInventory
113000
sonx Provision For Excess And Obsolete Inventory
ProvisionForExcessAndObsoleteInventory
294000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-824000
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
17031887
CY2021Q3 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
281342000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
176000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-105000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
655000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
593000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-2000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-64000
sonx Change In Fair Value Of Forward Obligation
ChangeInFairValueOfForwardObligation
-550000
sonx Change In Fair Value Of Forward Obligation
ChangeInFairValueOfForwardObligation
478000
sonx Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
12000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
8000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1360000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3011000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-344000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
575000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-258000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1472000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-276000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2216000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-158000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-323000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
709000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33880000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30872000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
485000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
824000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1297000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1782000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
175000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
41000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
450000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
667000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
987000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
5138000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
5138000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
35000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
30000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1335000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2312000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-976000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-37974000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-32672000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
51722000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
92165000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13748000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
59493000
us-gaap Interest Paid Net
InterestPaidNet
2577000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3122000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3380000
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
17528207
CY2021Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
17031887
us-gaap Interest Paid Net
InterestPaidNet
2577000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
362000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2790000
sonx Lease Liabilities For Operating Lease Right Of Use Assets
LeaseLiabilitiesForOperatingLeaseRightOfUseAssets
-362000
sonx Lease Liabilities For Operating Lease Right Of Use Assets
LeaseLiabilitiesForOperatingLeaseRightOfUseAssets
-2790000
sonx Noncash Or Part Noncash Fair Value Of Preferred Stock Warrants Issued
NoncashOrPartNoncashFairValueOfPreferredStockWarrantsIssued
2134000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
67000
sonx Noncash Or Part Noncash Deferred Offering Costs Included In Accrued Expenses
NoncashOrPartNoncashDeferredOfferingCostsIncludedInAccruedExpenses
538000
sonx Noncash Or Part Noncash Unpaid Deferred Financing Costs
NoncashOrPartNoncashUnpaidDeferredFinancingCosts
50000
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On October 20, 2021, the Company’s Board of Directors approved an amendment to the Company’s Articles of Incorporation to effect a reverse split of shares of the Company’s common stock and convertible preferred stock on a 1-for-1.825 basis (the “Reverse Stock Split”). The par values of the common stock and convertible preferred stock were not adjusted as a result of the Reverse Stock Split.
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13700000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-298300000
us-gaap Net Income Loss
NetIncomeLoss
-34800000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33900000
sonx Number Of Operating And Reportable Segments
NumberOfOperatingAndReportableSegments
2
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of financial statements in conformity with GAAP requires management to make informed estimates, judgements and assumptions that affect the reported amounts in the consolidated financial statements and disclosures in the accompanying notes, including estimates of probable losses and expenses, as of the date of the accompanying consolidated financial statements. Management considers many factors in selecting appropriate financial accounting policies and in developing the estimates and assumptions that are used in the preparation of these consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including the expected business and operational changes, the sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. Actual results could differ materially from the estimates and assumptions used in the preparation of the accompanying consolidated financial statements under different assumptions or conditions.</span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Concentration of Credit Risk</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash, cash equivalents and accounts receivable. The Company’s policy is to mitigate such potential risks by maintaining the Company’s cash balances with entities that management believes possess high credit quality to limit the amount of credit exposure. Substantially all of the Company’s cash and cash equivalents are maintained at one financial institution domiciled in the United States. Cash and cash equivalents can exceed amounts insured by the Federal Deposit Insurance Corporation of up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">250,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company has not experienced any losses in their accounts and management believes it is not exposed to any significant credit risk on cash and cash equivalents. The primary objectives of the Company’s investment portfolio are the preservation of capital and maintenance of liquidity.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company believes any concentration of credit risk in its accounts receivable is mitigated by its credit evaluation process, relatively short collection terms and the level of credit worthiness of its customers. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">One</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> customer accounted for approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of accounts receivable as of September 30, 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company sources materials and services through several vendors. Certain materials are sourced from a single vendor. The loss of certain vendors could result in a temporary disruption of the Company’s commercialization efforts.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company’s products require clearance from the FDA and foreign regulatory agencies before commercial sales can commence. There can be no assurance that the Company’s products in development will receive any of these required clearances. The denial or delay of such clearances may have a material adverse impact on the Company’s business in the future. In addition, after the clearance by the FDA, there is still an ongoing risk of adverse events that did not appear during the device clearance process.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is subject to risks common to companies in the medical device industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of its products, product liability and the need to obtain additional financing.</span></p>
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
308000
CY2021Q3 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
331503
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2222000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1916000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2021Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q3 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2021Q3 us-gaap Inventory Net
InventoryNet
7236000
CY2020Q4 us-gaap Inventory Net
InventoryNet
4338000
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
685000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
843000
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
5000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
684000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
838000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
900000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
500000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7887000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6132000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23306000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14680000
CY2021Q3 sonx Inventory Reserves For Excess And Obsolete
InventoryReservesForExcessAndObsolete
1100000
CY2020Q4 sonx Inventory Reserves For Excess And Obsolete
InventoryReservesForExcessAndObsolete
1300000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1172000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2208000
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1584000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
958000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1163000
CY2021Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1379000
CY2021Q3 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
996000
CY2021Q3 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
383000
CY2021Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1379000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
4663000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2114000
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
351000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
17031887
CY2021Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
17031887
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
281342000
CY2021Q3 sonx Temporary Equity Number Of Common Stock Equivalent Shares
TemporaryEquityNumberOfCommonStockEquivalentShares
17031887
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2021Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
331503
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
180819
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
166000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
664000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
618000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
442000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
386000
CY2021Q3 sonx Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
846000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3122000
sonx Finite Lived Intangible Asset Weighted Average Amortization Period
FiniteLivedIntangibleAssetWeightedAverageAmortizationPeriod
P7Y7M6D
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1914000
CY2021Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
4225000
sonx Number Of Classes Of Stock
NumberOfClassesOfStock
2
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 sonx Common Stock And Temporary Equity Shares Authorized
CommonStockAndTemporaryEquitySharesAuthorized
39172043
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21643836
CY2021Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
17528207
CY2021Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
17528207
CY2020Q3 us-gaap Lease Cost
LeaseCost
387000
us-gaap Lease Cost
LeaseCost
964000
us-gaap Lease Cost
LeaseCost
1027000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8495000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22400000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4633000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14310000
CY2020Q4 sonx Temporary Equity Number Of Common Stock Equivalent Shares
TemporaryEquityNumberOfCommonStockEquivalentShares
17031887
CY2021Q3 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
282198000
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
282198000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Each share of common stock is entitled to one vote.
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
541000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
465000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1448000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1175000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2247136
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
500877
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.08
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
154227
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.56
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
58290
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3286
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.73
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2532210
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.41
CY2021Q3 sonx Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
19000
sonx Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
12000
us-gaap Lease Cost
LeaseCost
964000
us-gaap Lease Cost
LeaseCost
1027000
CY2021Q3 us-gaap Lease Cost
LeaseCost
328000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
13147000
us-gaap Operating Expenses
OperatingExpenses
36722000
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1133123
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.10
CY2021Q3 sonx Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Early Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercised
205
CY2021Q3 sonx Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Early Exercised Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsEarlyExercisedWeightedAverageGrantDateFairValue
3.31
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
3.93
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2532210
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.47
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M1D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1399015
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
4.51
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y11M10D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17800000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
12600000
CY2021Q3 sonx Share Based Compensation Arrangement By Share Based Payment Award Estimate Fair Value Of Common Stock
ShareBasedCompensationArrangementByShareBasedPaymentAwardEstimateFairValueOfCommonStock
13.49
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2390577
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
6.33
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y1M28D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
17100000
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
The Company leases office space under operating leases with expirations ranging from April 2021 to March 2025, some of which include rent escalations or an option to extend the lease for up to three years per renewal.
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2021Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P3Y
CY2021Q3 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
300000
CY2020Q3 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
300000
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
900000
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
800000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
303000
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
308000
us-gaap Operating Lease Cost
OperatingLeaseCost
892000
us-gaap Operating Lease Cost
OperatingLeaseCost
819000
CY2020Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
54000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
143000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
25000
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
25000
us-gaap Variable Lease Cost
VariableLeaseCost
72000
us-gaap Variable Lease Cost
VariableLeaseCost
65000
CY2021Q3 us-gaap Lease Cost
LeaseCost
328000
CY2020Q3 us-gaap Lease Cost
LeaseCost
387000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2943000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3308000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
935000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
802000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1964000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2449000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2899000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3251000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y11M12D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0758
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M8D
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0755
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
303000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1202000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1049000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
617000
CY2021Q3 sonx Lessee Operating Lease Liability Payments Due After Year Three
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree
156000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3327000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
428000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2899000
us-gaap Gross Profit
GrossProfit
5884000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11098000
us-gaap Operating Income Loss
OperatingIncomeLoss
-30838000
CY2021Q3 sonx Gross Margin Percentage
GrossMarginPercentage
0.26
sonx Gross Margin Percentage
GrossMarginPercentage
0.25
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
30000000
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
30000000
CY2021Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.50
CY2021Q3 us-gaap Revenues
Revenues
7887000
us-gaap Revenues
Revenues
23306000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5838000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17422000
CY2021Q3 us-gaap Gross Profit
GrossProfit
2049000
CY2020Q3 us-gaap Revenues
Revenues
6132000
us-gaap Revenues
Revenues
14680000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4931000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12550000
CY2020Q3 us-gaap Gross Profit
GrossProfit
1201000
us-gaap Gross Profit
GrossProfit
2130000
CY2020Q3 sonx Gross Margin Percentage
GrossMarginPercentage
0.20
sonx Gross Margin Percentage
GrossMarginPercentage
0.15
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5802000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19423000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4920000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14551000
CY2020Q3 sonx Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
30000
sonx Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
-478000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
10752000
us-gaap Operating Expenses
OperatingExpenses
33496000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9551000
us-gaap Operating Income Loss
OperatingIncomeLoss
-31366000
CY2021Q3 us-gaap Assets
Assets
43416000
CY2020Q4 us-gaap Assets
Assets
76141000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12733000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-10593000
us-gaap Net Income Loss
NetIncomeLoss
-34788000
us-gaap Net Income Loss
NetIncomeLoss
-34138000
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1232921
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1197919
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1218815
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1194562
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-10.33
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-8.84
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-28.54
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-28.58
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20120442
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19682595

Files In Submission

Name View Source Status
0000950170-21-005123-index-headers.html Edgar Link pending
0000950170-21-005123-index.html Edgar Link pending
0000950170-21-005123.txt Edgar Link pending
0000950170-21-005123-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sonx-20210930.htm Edgar Link pending
sonx-20210930.xsd Edgar Link pending
sonx-20210930_cal.xml Edgar Link unprocessable
sonx-20210930_def.xml Edgar Link unprocessable
sonx-20210930_htm.xml Edgar Link completed
sonx-20210930_lab.xml Edgar Link unprocessable
sonx-20210930_pre.xml Edgar Link unprocessable
sonx-ex31_1.htm Edgar Link pending
sonx-ex31_2.htm Edgar Link pending
sonx-ex32_1.htm Edgar Link pending
sonx-ex32_2.htm Edgar Link pending